Keros Therapeutics (KROS) Net Cash Flow (QoQ) (2019 - 2025)
Keros Therapeutics (KROS) Net Cash Flow (QoQ) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Keros Therapeutics | 377.42 Mn | 90.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -12,567.21% |
| Sep 30, 2025 | 110.74% |
| Jun 30, 2025 | -118.88% |
| Mar 31, 2025 | 449.15% |
| Dec 31, 2024 | -76.61% |
| Sep 30, 2024 | 441.88% |
| Jun 30, 2024 | -132.87% |
| Mar 31, 2024 | 157.31% |
| Dec 31, 2023 | 226.30% |
| Sep 30, 2023 | -16.48% |
| Jun 30, 2023 | -140.62% |
| Mar 31, 2023 | 82.68% |
| Dec 31, 2022 | 66.44% |
| Sep 30, 2022 | 283.61% |
| Jun 30, 2022 | -790.45% |
| Mar 31, 2022 | -116.75% |
| Dec 31, 2021 | 159.73% |
| Sep 30, 2021 | 19.56% |
| Jun 30, 2021 | -69.49% |
| Mar 31, 2021 | -108.08% |